A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Prostate Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/5/2019 |
| Start Date: | February 21, 2018 |
| End Date: | February 18, 2022 |
| Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
| Email: | clinicaltrials.gov@lilly.com |
| Phone: | 1-317-615-4559 |
A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination With Anti- PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors
The purpose of this study is to evaluate the safety of the study drug LY3381916 administered
alone or in combination with anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody
(LY3300054).
alone or in combination with anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody
(LY3300054).
Inclusion Criteria:
- Participant must have histological or cytological evidence of a diagnosis of cancer
that is advanced and/or metastatic.
- Have adequate organ function.
- Have a performance status (PS) of ≤1 on the Eastern Cooperative Oncology Group (ECOG)
scale.
- Have discontinued previous treatments for cancer.
- Are able to swallow capsules.
Exclusion Criteria:
- Currently enrolled in a clinical study.
- Have a serious concomitant systemic disorder.
- Have a symptomatic human immunodeficiency virus infection or symptomatic
activated/reactivated hepatitis B or C.
- Have a significant cardiac condition.
- Have previously received an indoleamine- 2,3-dioxygenase (IDO) inhibitor.
We found this trial at
4
sites
250 25th Ave N, Ste 100
Nashville, Tennessee 37023
Nashville, Tennessee 37023
615-320-5090
Principal Investigator: Johanna Chock Bendell
Phone: 6153297274
Tennessee Oncology, PLLC Since 1976 Tennessee Oncology has been providing quality cancer care. In 2013,...
Click here to add this to my saved trials
121 Boulevard de Waterloo
Brussel, 1000
Brussel, 1000
Principal Investigator: Nuria Kotecki
Phone: 3225413059
Click here to add this to my saved trials
Indianapolis, Indiana 46202
Principal Investigator: Bert H O'Neil
Phone: 317-278-8845
Click here to add this to my saved trials
Nashville, Tennessee 37203
Principal Investigator: SMO Sarah Cannon Research Inst.
Phone: 615-329-7615
Click here to add this to my saved trials